发明名称 COMBINATION DOSAGE FORM OF A MU OPIOID RECEPTOR ANTAGONIST AND AN OPIOID AGENT
摘要 The invention provides a solid composition of the peripheral mu opioid antagonist axelopran and a combination dosage form of the mu opioid antagonist axelopran sulfate in an immediate release form and an opioid analgesic agent which may be in an extended release, sustained release, modified release, or controlled release form and methods of preparing such a combination dosage form.
申请公布号 WO2016161069(A1) 申请公布日期 2016.10.06
申请号 WO2016US25176 申请日期 2016.03.31
申请人 THERAVANCE BIOPHARMA R&D IP, LLC 发明人 LI, Shaoling;LEUNG, Manshiu;ZHANG, Hao;THALLADI, Venkat R.;MO, Yun
分类号 A61K31/439;A61K9/24;A61K9/28 主分类号 A61K31/439
代理机构 代理人
主权项
地址